Economy · 2 sources
Sun Pharma Inks Global Licensing Deal With LIB Therapeutics For PCSK9 Inhibitor
Coverage by lean
0% Left50% Centre50% Right
Left 0
No coverage found on this side
Centre 1
Right 1
One headline per side, the first Trikon holds. Every outlet is listed below.
Left · 0
No coverage found on this side.
Centre · 1
Free Press Journal · Centre
Sun Pharma Inks Global Licensing Deal With LIB Therapeutics For PCSK9 Inhibitor
Right · 1
Business Standard · Lean Right
Sun Pharma bags rights to $3.7 billion cholesterol drug market globally
Verify with IFCN fact-checkers →